These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23226652)

  • 1. Study of early atherosclerotic markers in women with polycystic ovary syndrome.
    Karoli R; Fatima J; Siddiqi Z; Vatsal P; Sultania AR; Maini S
    Indian J Endocrinol Metab; 2012 Nov; 16(6):1004-8. PubMed ID: 23226652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory and endothelial markers in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Alexandraki K; Piperi C; Protogerou A; Katsikis I; Paterakis T; Lekakis J; Panidis D
    Eur J Clin Invest; 2006 Oct; 36(10):691-7. PubMed ID: 16968464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease risk in the siblings of women with polycystic ovary syndrome.
    Karthik S; Vipin VP; Kapoor A; Tripathi A; Shukla M; Dabadghao P
    Hum Reprod; 2019 Aug; 34(8):1559-1566. PubMed ID: 31299073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No relationship between osteoprotegerin concentrations and endothelial dysfunction in non-obese women with and without polycystic ovary syndrome.
    Abali R; Tasdemir N; Alpsoy S; Tasdemir UG; Guzel S; Yuksel MA; Temel Yuksel I; Yilmaz M
    Arch Gynecol Obstet; 2015 May; 291(5):1075-80. PubMed ID: 25280574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome.
    Cascella T; Palomba S; De Sio I; Manguso F; Giallauria F; De Simone B; Tafuri D; Lombardi G; Colao A; Orio F
    Hum Reprod; 2008 Jan; 23(1):153-9. PubMed ID: 18024952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease risk in first-degree relatives of women with polycystic ovary syndrome.
    Vipin VP; Dabadghao P; Shukla M; Kapoor A; Raghuvanshi AS; Ramesh V
    Fertil Steril; 2016 May; 105(5):1338-1344.e3. PubMed ID: 26852421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome.
    Bicer M; Guler A; Unal Kocabas G; Imamoglu C; Baloglu A; Bilgir O; Yuksel A; Bozkaya G; Calan M
    Endocr Res; 2017 May; 42(2):145-153. PubMed ID: 27911121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of kallistatin with carotid intima-media thickness in women with polycystic ovary syndrome.
    Calan M; Guler A; Unal Kocabas G; Alarslan P; Bicer M; Imamoglu C; Yuksel A; Bozkaya G; Bilgir O
    Minerva Endocrinol; 2018 Sep; 43(3):236-245. PubMed ID: 28294594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome.
    Krentowska A; Łebkowska A; Jacewicz-Święcka M; Hryniewicka J; Leśniewska M; Adamska A; Kowalska I
    Endocrine; 2021 May; 72(2):400-410. PubMed ID: 33442790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.
    Brinkworth GD; Noakes M; Moran LJ; Norman R; Clifton PM
    BJOG; 2006 Nov; 113(11):1308-14. PubMed ID: 17059392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.
    Samy N; Hashim M; Sayed M; Said M
    Dis Markers; 2009; 26(4):163-70. PubMed ID: 19729797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome.
    Tripathy P; Sahu A; Sahu M; Nagy A
    Eur J Obstet Gynecol Reprod Biol; 2017 Oct; 217():18-22. PubMed ID: 28850821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for visfatin as an independent predictor of endothelial dysfunction in polycystic ovary syndrome.
    Pepene CE
    Clin Endocrinol (Oxf); 2012 Jan; 76(1):119-25. PubMed ID: 21740456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease risk in young Indian women with polycystic ovary syndrome.
    Guleria AK; Syal SK; Kapoor A; Kumar S; Tiwari P; Dabadghao P
    Gynecol Endocrinol; 2014 Jan; 30(1):26-9. PubMed ID: 24020937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?
    Soares GM; Vieira CS; Martins WP; Franceschini SA; dos Reis RM; Silva de Sá MF; Ferriani RA
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):406-11. PubMed ID: 19094071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and cardiovascular risk factors in women with PCOS who have normal glucose tolerance test.
    Yildir IC; Kutluturk F; Tasliyurt T; Yelken BM; Acu B; Beyhan M; Erkorkmaz U; Yilmaz A
    Gynecol Endocrinol; 2013 Feb; 29(2):148-51. PubMed ID: 23127112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between glomerular filtration rate, and metabolic and inflammatory parameters in obese and non-obese patients with polycystic ovary syndrome.
    Can M; Duran C; Guney I; Elmas H; Ayhan M; Erdem SS
    Clin Investig Arterioscler; 2020; 32(6):256-262. PubMed ID: 32773256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Risk Predictors High Sensitivity C-Reactive Protein and Plasminogen Activator Inhibitor-1 in Women with Lean Phenotype of Polycystic Ovarian Syndrome: A Prospective Case-Control Study.
    Shah AK; Yadav BK; Shah AK; Suri A; Deo SK
    J Lab Physicians; 2023 Mar; 15(1):31-37. PubMed ID: 37064963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.